When Are Semaglutide Side Effects at Their Worst — and What to Expect

GI side effects (nausea, diarrhoea, indigestion) are most common in the first few weeks and after dose increases, they are often temporary.
Serious signs (severe stomach pain radiating to the back, signs of dehydration, or allergic reactions) need urgent medical attention, not a wait-and-see approach.
The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, though infrequent, serious risk with GLP-1 medicines.
Suspected side effects from any medicine, including semaglutide, can be reported directly at yellowcard.mhra.gov.uk.

The worst side effects of semaglutide tend to hit hardest in the first two to four weeks of treatment and in the 24 to 72 hours after each dose increase. For most people this means nausea, stomach discomfort or loose stools that arrive with the early doses and ease as the body adjusts. These are prescription-only medicines, and a qualified prescriber assesses your full health picture before treatment begins — the timing and severity of side effects is one of the things our prescribers work through with every person at the consultation stage.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the side-effect timeline shapes your decision about starting or staying on semaglutide

The first few weeks: why this window is the hardest

Semaglutide works partly by slowing the movement of food through the stomach. That mechanism is effective for appetite control, but it also explains why the gut complains most loudly at the start. When the first dose goes in, the body has had no time to adapt. Nausea is the most commonly reported side effect, often peaking in the day or two after the injection, then fading before the next weekly dose.

Constipation, burping, reflux and fatigue are also more noticeable in this early phase. Headaches and dizziness appear for some people, usually settling within the first fortnight. If you want a fuller picture before starting, our page on what are the side effects of taking semaglutide covers the full range reported in clinical use. The question most people are really asking is: does it get easier? For a large proportion of people, yes, though the answer is individual.

Eating smaller portions, avoiding rich or fatty food, and staying well hydrated all reduce the intensity of early nausea. None of that replaces clinical guidance, but our Wegovy side effects page covers practical coping detail your prescriber can tailor to your situation.

After each dose step-up: the cycle repeats, usually more mildly

Semaglutide's dosing schedule starts low and climbs in stages roughly every four weeks. Each time the dose increases, the GI symptoms can return briefly, a mild echo of the original adjustment period. This is expected and does not mean something has gone wrong.

The pattern matters for planning. If a dose increase lands on a Monday, a few days of queasiness that week is normal. Knowing that in advance (rather than being surprised by it) makes a real difference to how people manage. A question our prescribers hear regularly is whether to push through or hold the dose; the answer depends on how well the symptoms are tolerated, and that is exactly the kind of decision that belongs in a clinical conversation, not a forum.

For context on how quickly side effects tend to appear after each injection, the timeline of when semaglutide side effects start sets out what the evidence shows day by day. Severity varies considerably between individuals, some people move through every dose step with little disruption; others need more time at a given level before the prescriber considers moving up.

When to get medical help, and what cannot wait

Most semaglutide side effects are uncomfortable rather than dangerous. A handful of signs, though, need prompt attention. Severe, persistent abdominal pain that spreads to the back (with or without vomiting) should not be managed at home. Acute pancreatitis is a known, infrequent but serious risk with GLP-1 medicines; the MHRA Drug Safety Update from January 2026 made this explicit and asked prescribers and patients to remain alert to the symptom.

Other signs that warrant urgent help: symptoms of gallbladder problems (severe pain in the upper right abdomen), dehydration from prolonged vomiting or diarrhoea (little urination, dizziness on standing), signs of a serious allergic reaction (swelling of the face, lips or throat, breathing difficulty), or a rapid or irregular heartbeat. Low mood or thoughts of self-harm are also listed in prescribing information as requiring prompt reporting to a clinician.

If you are unsure whether a symptom needs attention, call 111 or speak to a GP. If it is severe or rapidly worsening, call 999 or go to A&E. Any suspected reaction can also be reported to the MHRA's Yellow Card scheme, that reporting genuinely helps the regulator monitor medicines in real-world use.

Deciding whether the side-effect window is manageable for you

The decision of whether to start semaglutide (and how to handle the weeks when symptoms peak) is personal, and it depends on more than the medicine itself. Health history, other medicines, lifestyle and individual tolerance all feed into it. For people transferring from another treatment or stepping up to a higher maintenance dose, the picture is slightly different again; if you want to understand what the side effects from semaglutide look like across the full course of treatment, that is worth reading separately from the early adjustment phase.

What the evidence broadly shows: GI symptoms are most intense early on, improve with time for most people, and return briefly with each dose increase before settling. That pattern is confirmed in published trial data and in the NHS guidance that describes how Wegovy works in clinical practice. Serious adverse events are infrequent, though not impossible, which is why clinical oversight throughout treatment matters, and our dedicated page on what the worst side effects of Wegovy are explains which signs to take most seriously.

At nume, a real prescriber reviews your consultation the same day, not software, not a checklist. Side effects, health history and suitability are all part of that review. If you would like to talk through whether semaglutide is appropriate for you, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions